<DOC>
	<DOCNO>NCT00311870</DOCNO>
	<brief_summary>The aim study compare renoprotective effect long act calcium antagonist ( nisoldipine ) angiotensin convert enzyme inhibitor ( lisinopril ) type 1 diabetic patient diabetic kidney disease . In total , 51 patient randomise treatment one drug 4 year . Changes kidney function , blood pressure urinary excretion albumin measure every 6 month</brief_summary>
	<brief_title>Renoprotective Effect Nisoldipine Lisinopril Type 1 Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Nisoldipine</mesh_term>
	<criteria>diabetic nephropathy , type 1 diabetes , hypertension child bear potential , nondiabetic kidney disease , malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 1999</verification_date>
</DOC>